Lactose (India) Ltd | 151 Cr. | 120 | 247/84.3 | 34.4 | 46.7 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
MPS Pharmaa Ltd | 3.96 Cr. | 2.07 | 4.33/1.90 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,993 Cr. | 458 | 465/192 | 112 | 22.8 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 38.1 Cr. | 51.3 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.9 Cr. | 20.4 | 29.1/17.0 | 31.2 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 61.7 Cr. | 82.0 | 134/78.9 | 16.3 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 52,360 Cr. | 1,855 | 2,286/1,275 | 39.3 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 324 Cr. | 14.2 | 22.5/10.8 | 19.7 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 784 Cr. | 1,661 | 1,682/635 | 33.4 | 299 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 116 Cr. | 23.2 | 32.0/15.0 | 35.5 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 802 Cr. | 272 | 449/219 | 7.67 | 123 | 0.92 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 14.7 Cr. | 5.89 | 9.28/2.11 | 8.34 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 375 Cr. | 386 | 477/112 | 60.4 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 4,887 Cr. | 1,123 | 1,584/1,045 | 47.7 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 65.4 Cr. | 0.32 | 1.24/0.31 | 4.31 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 47.4 Cr. | 19.7 | 26.3/6.40 | 48.9 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 9.94 Cr. | 9.84 | 17.2/9.40 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
Coral Laboratories Ltd | 178 Cr. | 498 | 896/443 | 9.63 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 62.0 Cr. | 62.0 | 71.2/26.1 | 159 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
Concord Biotech Ltd | 15,927 Cr. | 1,522 | 2,452/1,345 | 44.6 | 173 | 0.70 % | 28.4 % | 21.4 % | 1.00 |
Colinz Laboratories Ltd | 19.2 Cr. | 42.0 | 88.7/37.6 | 40.0 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 15.5 Cr. | 6.21 | 6.21/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 18.8 Cr. | 125 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 32.5 Cr. | 59.4 | 63.1/9.41 | 361 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 31.0 Cr. | 41.1 | 80.0/0.00 | 43.7 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 5.78 Cr. | 19.2 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 11,497 Cr. | 663 | 1,028/464 | 32.1 | 65.3 | 0.18 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 92.9 Cr. | 21.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 11.3 Cr. | 22.3 | 43.7/17.4 | 49.2 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
Mankind Pharma Ltd | 1,00,944 Cr. | 2,446 | 3,055/2,115 | 55.8 | 355 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
BDH Industries Ltd | 255 Cr. | 443 | 524/241 | 26.8 | 119 | 1.02 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 61.7 Cr. | 43.0 | 62.6/31.6 | 55.6 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
Aurobindo Pharma Ltd | 64,483 Cr. | 1,100 | 1,466/994 | 19.0 | 557 | 0.36 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 139 Cr. | 223 | 303/170 | 201 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 813 Cr. | 81.1 | 123/74.0 | 17.6 | 32.5 | 1.85 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 41.0 Cr. | 31.4 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
Acutaas Chemicals Ltd | 14,643 Cr. | 1,789 | 1,868/728 | 65.4 | 160 | 0.08 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 3.63 Cr. | 0.55 | 1.45/0.55 | 72.6 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 255 Cr. | 33.3 | 68.0/30.0 | 13.6 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.01 Cr. | 15.4 | 25.5/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 140 Cr. | 5.93 | 6.57/2.82 | 325 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 64,292 Cr. | 30,255 | 37,000/25,260 | 44.3 | 1,992 | 1.57 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,677 Cr. | 847 | 972/550 | 28.8 | 220 | 0.59 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 252 Cr. | 89.0 | 89.8/31.3 | 60.7 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,869 Cr. | 1,605 | 1,614/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 22,305 Cr. | 1,373 | 1,870/1,040 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 773 Cr. | 235 | 330/154 | 18.0 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
Venus Remedies Ltd | 609 Cr. | 455 | 568/270 | 13.0 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,270 Cr. | 464 | 950/455 | 26.2 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,685 Cr. | 1,193 | 1,616/991 | 23.9 | 768 | 0.84 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,21,527 Cr. | 3,591 | 3,790/2,886 | 60.2 | 224 | 0.89 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,162 Cr. | 126 | 317/98.0 | | 43.7 | 0.40 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,576 Cr. | 16.8 | 24.0/14.1 | 27.7 | 3.62 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
Cohance Lifesciences Ltd | 34,366 Cr. | 898 | 1,360/856 | 97.7 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 4,492 Cr. | 197 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,05,608 Cr. | 1,690 | 1,924/1,547 | 35.4 | 301 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,674 Cr. | 600 | 886/441 | 109 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,563 Cr. | 289 | 319/175 | 36.5 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 340 Cr. | 1,123 | 1,680/956 | 19.7 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 7,220 Cr. | 369 | 502/265 | 56.2 | 121 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 5,178 Cr. | 206 | 232/111 | 172 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 10,995 Cr. | 4,774 | 6,899/4,146 | 30.8 | 340 | 2.45 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,989 Cr. | 2,412 | 2,776/1,772 | 35.8 | 335 | 0.83 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,245 Cr. | 6,172 | 6,739/4,863 | 34.1 | 323 | 2.03 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 171 Cr. | 48.6 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 24,482 Cr. | 5,352 | 5,993/3,701 | 36.2 | 922 | 0.65 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 8.76 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
Panacea Biotec Ltd | 2,717 Cr. | 444 | 582/278 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,701 Cr. | 730 | 1,998/604 | 43.4 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,870 Cr. | 16,267 | 18,100/10,060 | 158 | 1,188 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 294 Cr. | 13.1 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,081 Cr. | 842 | 1,505/660 | 8.88 | 425 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,693 Cr. | 49.2 | 91.7/41.7 | 29.1 | 21.1 | 0.41 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 8,166 Cr. | 180 | 359/162 | 23.3 | 54.4 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 111 Cr. | 70.0 | 130/65.5 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
Lyka Labs Ltd | 337 Cr. | 94.5 | 177/90.2 | 45.0 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 88,716 Cr. | 1,942 | 2,403/1,774 | 24.0 | 377 | 0.62 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,057 Cr. | 528 | 980/499 | 12.2 | 335 | 0.34 % | 17.3 % | 12.8 % | 10.0 |
Laurus Labs Ltd | 49,874 Cr. | 924 | 944/440 | 97.9 | 84.6 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 927 Cr. | 894 | 1,235/596 | 21.3 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 152 Cr. | 70.4 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 818 Cr. | 169 | 327/154 | 23.4 | 107 | 1.77 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 656 Cr. | 375 | 500/265 | 23.4 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 18,219 Cr. | 1,144 | 1,310/802 | 37.5 | 393 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,477 Cr. | 1,691 | 1,998/1,303 | 38.6 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,478 Cr. | 222 | 328/175 | 34.7 | 36.1 | 1.13 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 32,507 Cr. | 1,281 | 1,758/1,168 | 36.3 | 274 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,793 Cr. | 95.2 | 127/57.5 | 26.5 | 57.5 | 0.84 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 771 Cr. | 105 | 124/67.2 | 34.9 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
Indoco Remedies Ltd | 2,655 Cr. | 288 | 355/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,005 Cr. | 244 | 465/236 | 47.5 | 102 | 0.57 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,475 Cr. | 1,734 | 2,786/1,243 | 39.2 | 369 | 0.40 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,506 Cr. | 350 | 504/285 | 57.4 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
Granules India Ltd | 13,833 Cr. | 570 | 628/412 | 29.0 | 153 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 52,360 Cr. | 1,855 | 2,286/1,275 | 39.3 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,736 Cr. | 2,759 | 3,516/1,921 | 49.4 | 115 | 1.52 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,674 Cr. | 1,922 | 2,131/1,200 | 27.9 | 592 | 0.94 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,307 Cr. | 449 | 559/359 | 27.2 | 140 | 1.11 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 21,597 Cr. | 1,586 | 1,910/1,097 | 55.8 | 210 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,07,557 Cr. | 1,289 | 1,406/1,020 | 18.9 | 402 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,537 Cr. | 289 | 322/169 | 38.2 | 372 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
Cipla Ltd | 1,34,380 Cr. | 1,664 | 1,669/1,310 | 24.9 | 386 | 0.78 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 15,430 Cr. | 2,030 | 2,641/1,551 | 27.3 | 347 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
Brooks Laboratories Ltd | 356 Cr. | 121 | 203/95.6 | 176 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,648 Cr. | 156 | 191/105 | 15.5 | 99.7 | 0.32 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 64.5 Cr. | 39.7 | 73.3/38.0 | 23.1 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 48,946 Cr. | 366 | 406/291 | 135 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,838 Cr. | 1,820 | 2,215/1,430 | 40.1 | 195 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
Bal Pharma Ltd | 129 Cr. | 81.3 | 141/76.3 | 18.1 | 48.6 | 1.48 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 334 Cr. | 141 | 179/67.8 | 33.1 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 23,266 Cr. | 9,306 | 10,691/6,220 | 110 | 308 | 0.34 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,071 Cr. | 716 | 843/544 | 38.0 | 113 | 0.64 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 186 Cr. | 88.3 | 137/85.0 | 7.05 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 66,329 Cr. | 5,548 | 6,186/4,492 | 29.2 | 1,002 | 0.81 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,335 Cr. | 933 | 1,156/725 | 30.9 | 264 | 1.18 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 456 Cr. | 798 | 1,540/763 | 72.4 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 30,579 Cr. | 2,448 | 3,181/2,022 | 32.9 | 303 | 1.14 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,516 Cr. | 314 | 509/258 | 25.7 | 127 | 1.66 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,743 Cr. | 516 | 575/312 | 26.5 | 136 | 0.19 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 20,038.24 Cr | 1,197.65 | | 50.64 | 194.07 | 0.33% | 16.24% | 14.95% | 6.10 |